slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,551-5,580
Pages 296
Rows per page 30
Slide type
5,551-5,580 of 8,880
20
The slide uses a circular process diagram to illustrate the integration of various data sources into the Centaur Biologist engine.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
The slide uses a process flow diagram to show how target criteria are translated into code-based optimization and then visualized as project telemetry.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The diagram uses a hub-and-spoke style flow to show data integration, model selection, generative design, and an iterative experimental feedback loop.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
25
The scatter plot shows a Pareto-like frontier of compounds, with the AI selecting specific points (labeled 1 and 2) that are not necessarily the highest-performing in isolation but provide high information gain.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
31
The slide displays a heatmap of 43 patient samples showing ABS scores, signature scores, and cancer diagnoses.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
39
The slide uses a three-column layout to define the target product profile (TPP) requirements for a CDK7 inhibitor.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
43
The right chart is a waterfall plot showing drug response scores across 53 patient samples, categorized by tumor type and responder status.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
46
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
48
The slide uses a process-flow layout to describe the company's proprietary drug discovery methodology.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
49
The slide uses a high-impact visual of a protein-ligand interaction to establish the product's identity.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
50
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
51
Includes two distinct biological diagrams/illustrations and citations for scientific literature.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
52
The slide uses a three-column layout to define the technical requirements for the drug candidate.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
55
The chart illustrates a Pareto front analysis in drug discovery, highlighting the selection of compounds that are not necessarily 'optimal' by standard metrics but provide high information value.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
57
The slide uses two distinct chart types (dot plot and line chart) to contrast the safety profiles of reversible vs irreversible LSD1 inhibitors.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
59
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
61
The background features a 3D molecular visualization, likely representing the MALT1 protein structure.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
62
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
64
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
68
The slide highlights the technical methodology behind a specific drug candidate ('565) using molecular dynamics.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
70
The chart shows tumor volume over time (D20-D30) for various treatment groups, highlighting the superior performance of the combination therapy.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
03
The slide uses a collage of imagery representing political, legislative, and data-driven environments to reinforce the 'What We Do' statement.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · Solution1 hit
11
FiscalNote | Investor Presentation Deck | 32 slidesFiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · ProductLoop · Quick Win Big Bet1 hit
12
The slide uses a process flow diagram to illustrate the company's proprietary data infrastructure.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
14
The left side uses a tree metaphor to show the foundation (AI/ML/NLP) supporting various research and compliance applications. The right side uses an icon grid to list target sectors.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
04
Genelux | Investor Presentation Deck | 38 slidesGenelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
06
Uses a process diagram to illustrate the transition from cold to hot tumor states.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
07
The central diagram illustrates the biological mechanism of action, contrasting the absence vs. presence of effector T cells.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Solution1 hit
38
The slide uses clinical study data (VIRO-15, NCT01443260) to support its claims about immune modulation.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations 1 hit